Piramal Pharma Limited Announces Results for Q1FY26

About this update from Piramal Pharma Limited

[{"type":"text","content":"MUMBAI, India, July 28, 2025 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, and health and wellness company, today announced its standalone and consolidated results for the First Quarter (Q1) ended 30th June 2025.","length":270,"tagName":"p"},{"type":"image","alt":"Piramal Pharma Ltd Logo","displaySize":"","headline":null,"caption":"Piramal Pharma Ltd Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":164,"url":"https://media.zenfs.com/en/prnewswire.com/966a48416217238388617c8e1eced2d5"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/rdN24JILqWR9n9kHLJMu.w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTI4OTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/966a48416217238388617c8e1eced2d5","width":400,"height":164}}},{"type":"text","content":" ","length":6,"tagName":"p"},{"type":"text","content":" ","length":6,"tagName":"p"},{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"4","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;","val":[{"type":"text","content":"Consolidated Financial Highlights","length":33,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"4","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;TEXT-ALIGN:RIGHT;","val":[{"type":"text","content":"(in ₹ Crores or as stated)","length":26,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;","val":[{"type":"text","content":"Particulars","length":11,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;TEXT-ALIGN:CENTER;","val":[{"type":"text","content":"Q1FY26","length":6,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;TEXT-ALIGN:CENTER;","val":[{"type":"text","content":"Q1FY25","length":6,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;TEXT-ALIGN:CENTER;","val":[{"type":"text","content":"YoY Growth","length":10,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":...

More updates from Piramal Pharma Limited